- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01809951
Isomil Post Marketing Observational Study
June 14, 2017 updated by: Melva Louisa
A Prospective, Open-label, Post-marketing Observational Study to Document the Use of Soy-based Infant Formula With Low Chain Polyunsaturates (LCP) in Infants With Symptoms Suggestive to Cow's Milk Allergy
The use of soy-isolate protein based formula for infants with cow's milk protein intolerance is common in Indonesia, however, there has not been any systematic collection of clinical data to determine the formula's gastrointestinal tolerance, and the parent's perceptions regarding the formula.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
534
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jakarta, Indonesia, 10430
- Divisi Alergi Imunologi FKUI RSCM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Infants with symptoms suggestive adverse reactions to cow's milk protein
Description
Inclusion Criteria:
- infants of 6 - 12 months of age
- full term infants
- birth weight more than 2500 grams
- infants developed symptoms suggestive adverse reactions to cow's milk protein in the investigator's clinical judgements
- subject is prescribed a soy-based infant formula by physician
Exclusion Criteria:
- established/suspected hypersensitivity fo soy
- presence of adverse reactions to cow's milk caused by coincidental infections or other systemic disease
- history of blood group incompatibility, premature delivery, HIV infections, major congenital abnormalities, systemic diseases
- presence of severe gastrointestinal disorder
- subject is participating in any interventional clinical study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Isomil Advance with LCP
4 spoonful of Isomil Advance with LCP in 240 mL of water, 4 times a day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Parent's acceptance in the feeding of a soy-based infant formula with LCP in infants with symptoms suggestive adverse reactions to cow milk protein
Time Frame: 4-week
|
4-week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
percentage of infants with gastrointestinal adverse events
Time Frame: 4-week
|
4-week
|
percentage of infants with adverse events
Time Frame: 4-week
|
4-week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zakiudin Munasir, MD, PhD, Division of allergy and Immunology, Department of Child Health, Faculty of Medicine, Universitas Indonesia
- Study Chair: Sumadiono, MD, PhD, RS Sardjito, Jl Kesehatan No 1 Yogyakarta
- Study Chair: Anang Endaryanto, MD, PhD, Allergy Immunology Working Unit, East Java Branch of Indonesian Pediatric Society
- Study Chair: Dina Muktiarti, MD, Sub Divisi Alergi Imunologi IKA FKUI, Jakarta
- Study Chair: Dewi Kumara Wati, MD, PhD, RSUP Sanglah, Jl Kesehatan No 1-10 Denpasar Bali
- Study Chair: Budi Setiabudiawan, MD, PhD, RS Hasan Sadikin Jl Pasteur No 38 Bandung
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2011
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
January 25, 2013
First Submitted That Met QC Criteria
March 11, 2013
First Posted (Estimate)
March 13, 2013
Study Record Updates
Last Update Posted (Actual)
June 16, 2017
Last Update Submitted That Met QC Criteria
June 14, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ANID-1101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cow's Milk Allergy
-
University of Campinas, BrazilCompleted
-
Edetec Indústria Alimentícia S.A.Federal University of Minas Gerais; Faculdade de Ciências Médicas de Minas...CompletedCow's Milk Allergy
-
Laboratorios OrdesaSprim Advanced Life SciencesTerminatedCow's Milk AllergySpain, France
-
Federico II UniversityRecruiting
-
Société des Produits Nestlé (SPN)Completed
-
Assistance Publique - Hôpitaux de ParisESPCI ParisCompleted
-
Martini Hospital GroningenRecruitingCow Milk Allergy | Food AllergyNetherlands
-
University GhentActive, not recruitingCow Milk Allergy | Food AllergyBelgium
-
Federico II UniversityUnknown